(Q43573977)

24 November 2017

title

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy (English)

1 reference

24 November 2017

0 references

1 reference

0 references

9

1 reference

24 November 2017

Taina Sipponen

1

1 reference

24 November 2017

Johanna Haapamäki

2

1 reference

24 November 2017

Erkki Savilahti

3

1 reference

24 November 2017

Henrik Alfthan

4

1 reference

24 November 2017

Esa Hämäläinen

5

1 reference

24 November 2017

Henna Rautiainen

6

1 reference

24 November 2017

Jari Koskenpato

7

1 reference

24 November 2017

Hannu Nuutinen

8

1 reference

24 November 2017

publication date

23 April 2012

1 reference

Scandinavian Journal of Gastroenterology

24 November 2017

published in

1 reference

24 November 2017

volume

47

1 reference

24 November 2017

issue

7

1 reference

24 November 2017

page(s)

778-784

1 reference

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Prophylactic aspirin therapy does not increase faecal calprotectin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

High prevalence of NSAID enteropathy as shown by a simple faecal test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

Can chronic gastritis cause an increase in fecal calprotectin concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.677953

10.3109/00365521.2012.677953

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference